SOCS5 Antibody

What is SOCS5 and why is it important in research?

SOCS5 belongs to the Suppressor of Cytokine Signaling (SOCS) family, which functions as negative regulators of cytokine signaling pathways. It plays a crucial role in controlling the intensity and duration of immune responses by regulating JAK/STAT signaling and epidermal growth factor receptor (EGFR) pathways. SOCS5 is a key player in T cell differentiation, antiviral immunity, and potentially acts as a tumor suppressor .

Research has demonstrated that SOCS5 specifically:

• Negatively regulates cytokine signaling, particularly via JAK1 and JAK2 inhibition

• Modulates EGFR signaling through interactions with Shc-1

• Shows differential expression in Th1 versus Th2 cells

• Restricts influenza virus replication in airway epithelium

• May have tumor-suppressive functions in certain cancers

What are the main types of SOCS5 antibodies available for research?

SOCS5 antibodies are available in several formats to accommodate various experimental approaches:

Many of these antibodies show cross-reactivity with multiple species including human, mouse, rat, pig, chicken, and non-human primates, making them versatile for comparative studies across species .

What are the specific domains of SOCS5 and why are they important for antibody targeting?

SOCS5 contains several functional domains that are important for its biological activity and can be targeted by different antibodies:

• N-terminal region (including the JAK interaction region or JIR): Responsible for direct interaction with JAK proteins

• SH2 domain: Binds to phosphorylated tyrosine residues on target proteins

• SOCS box: Mediates interaction with the E3 ubiquitin ligase complex

The selection of antibodies targeting specific domains depends on the research question. For instance, antibodies recognizing the N-terminal region might be particularly useful for studying JAK-SOCS5 interactions, while those targeting the SH2 domain may help investigate SOCS5-Shc-1 or other phosphotyrosine-mediated interactions .

How should I optimize Western blotting protocols using SOCS5 antibodies?

For optimal Western blot results with SOCS5 antibodies, consider the following methodological approach:

• Sample preparation:

  • Use KALB lysis buffer containing protease inhibitors (Complete Cocktail tablets), 1 mM PMSF, 1 mM Na₃VO₄, and 1 mM NaF

  • Consider pre-treatment with MG132 (10 μM) for 3-6 hours to inhibit proteasomal degradation of SOCS5

  • Treatment with pervanadate solution (H₂O₂/25 μM Na₃VO₄) for 20-30 minutes may enhance phosphorylation status

• Electrophoresis and transfer:

  • Separate proteins on SDS-PAGE under reducing conditions

  • Transfer to PVDF or nitrocellulose membranes

  • Use 4x Laemmli reducing sample buffer for sample loading

• Antibody incubation:

  • Block membranes in 10% w/v skim milk overnight

  • Primary antibody dilutions typically range from 1:500-1:3000 for Western blot applications

  • Incubate with primary antibody for 2 hours at room temperature

  • Use appropriate HRP-conjugated secondary antibodies for detection

• Detection:

  • Visualize using enhanced chemiluminescence (ECL) systems

  • SOCS5 typically appears as a band at approximately 61-65 kDa

What are the recommended protocols for immunoprecipitation studies with SOCS5 antibodies?

For successful immunoprecipitation of SOCS5 or SOCS5-interacting proteins:

• Cell preparation:

  • Pre-treat cells with 10 μM MG132 for 3-6 hours to stabilize SOCS5 protein

  • Treat with pervanadate solution (H₂O₂/25 μM Na₃VO₄) for 30 minutes to enhance phosphorylation status

• Lysis conditions:

  • For SOCS5-JAK interactions: Use KALB lysis buffer with protease inhibitors

  • For SOCS5-Shc-1 co-immunoprecipitation: Use 1% NP-40 buffer (1% v/v NP-40, 50 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM NaF, 1 mM Na₃VO₄)

• Pre-clearing and immunoprecipitation:

  • Pre-clear lysates with protein-A-Sepharose for 1.5 hours

  • For Flag-tagged proteins: Use anti-Flag antibody conjugated to Sepharose (M2)

  • For endogenous SOCS5: Use 5 μg in-house antibody and protein-A Sepharose

• Detection of interactions:

  • Separate immunoprecipitates by SDS-PAGE

  • Perform Western blotting with appropriate antibodies to detect SOCS5 or interacting partners

  • For re-blotting, strip membranes with 0.1 M glycine, pH 2.9

What is the recommended approach for immunohistochemistry and immunofluorescence using SOCS5 antibodies?

For effective immunohistochemistry and immunofluorescence:

• Sample preparation:

  • For paraffin-embedded sections: Use standard formalin fixation and paraffin embedding protocols

  • For immunofluorescence on cells: Use immersion fixation methods

• Antibody dilutions and incubation:

  • For IHC-P: Use dilutions ranging from 1:50-1:200 (more concentrated) or 1:100-1:1000 (more dilute) depending on the specific antibody

  • For immunofluorescence: Concentrations around 15 μg/mL have been reported effective for cellular staining

  • Incubate primary antibody for 3 hours at room temperature

• Detection systems:

  • For immunofluorescence: Use species-appropriate fluorophore-conjugated secondary antibodies (e.g., NorthernLights™ 557-conjugated Anti-Goat IgG)

  • Counterstain nuclei with DAPI for context

• Expected staining pattern:

  • SOCS5 typically shows cytoplasmic localization

  • In cell lines like Jurkat (human acute T cell leukemia), specific staining is observed in the cytoplasm

How can SOCS5 antibodies be used to investigate differential expression in Th1 versus Th2 cells?

SOCS5 shows differential expression in Th1 versus Th2 cells, making it a valuable marker for T cell differentiation studies:

• Experimental approach:

  • Generate Th1 and Th2 cells from naive T cells using standard polarization protocols

  • Analyze SOCS5 protein expression by Western blotting

  • Compare with SOCS3 and SOCS1 expression patterns

  • Confirm findings with mRNA analysis (RT-PCR)

• Expected results:

  • SOCS5 protein is preferentially expressed in Th1 cells but minimal in Th2 cells

  • In contrast, SOCS3 protein is found predominantly in Th2 cells

  • SOCS1 protein is equally expressed in both Th1 and Th2 cells

• Functional assessment:

  • Investigate SOCS5 interaction with IL-4Rα in Th1 and Th2 cells through co-immunoprecipitation

  • SOCS5 preferentially co-precipitates with the endogenous IL-4R α chain in Th1 cells

  • This correlates with impaired Jak1 association with the IL-4R in Th1 cells, suggesting SOCS5 competes with Jak1 for receptor binding

How can SOCS5 antibodies be used to study its role in viral infections?

SOCS5 has emerged as a critical regulator of antiviral responses, particularly in respiratory viral infections:

• Experimental design for influenza infection studies:

  • Compare wild-type and SOCS5-deficient mice challenged with influenza virus

  • Monitor weight loss, viral titers, and inflammatory responses

  • Use SOCS5 antibodies to assess protein expression in airway epithelial cells

• Key measurements and analyses:

  • Viral load in lung homogenates

  • Cytokine and chemokine profiling (IL-6, G-CSF, KC, MCP-1, MIP-1β, IFNα, IFNβ, IFNλ)

  • Immune cell infiltration (neutrophils, monocytes, T cells, B cells)

  • SOCS5 protein levels in healthy versus infected cells

• Expected findings in SOCS5-deficient models:

  • Increased susceptibility to influenza infection

  • Enhanced weight loss and viral titers

  • Elevated inflammatory cytokine production

  • Increased neutrophil infiltration

  • Correlation between reduced SOCS5 levels and increased viral replication

• Application to human disease models:

  • SOCS5 levels are reduced in primary epithelial cells from COPD patients

  • This correlates with increased susceptibility to influenza infection

  • Restoration of SOCS5 levels restricts viral replication

What is the relationship between SOCS5 and cell signaling pathways, and how can antibodies help elucidate these mechanisms?

SOCS5 regulates multiple signaling pathways through distinct mechanisms:

• JAK/STAT pathway regulation:

  • SOCS5 directly interacts with JAK1 and JAK2 (but not JAK3 or TYK2) via its JAK interaction region (JIR)

  • Use co-immunoprecipitation with SOCS5 antibodies to detect JAK-SOCS5 interactions

  • Assess JAK autophosphorylation in the presence and absence of SOCS5

  • SOCS5 can inhibit JAK1 kinase activity through a mechanism distinct from SOCS1 and SOCS3

• EGFR pathway regulation:

  • SOCS5 interacts with the EGFR signaling pathway through binding to phosphoTyr317 in Shc-1

  • Use SOCS5 antibodies to detect SOCS5-Shc-1 interactions via co-immunoprecipitation

  • The SOCS5-SH2 domain shows high affinity for the phosphoTyr317 site in Shc-1

  • This interaction may allow SOCS5 to negatively regulate EGF and growth factor-driven Shc-1 signaling

• PI3K/AKT pathway:

  • SOCS5 regulates PI3K p110α levels and activity

  • Depletion of SOCS5 enhances PI3K p110α expression and AKT phosphorylation

  • Forced SOCS5 expression reduces p110α and EGFR levels and phosphorylation

  • Use SOCS5 antibodies to assess these regulatory relationships in various cell types

What are common issues when using SOCS5 antibodies and how can they be resolved?

• Low or no signal in Western blots:

  • SOCS5 is often expressed at low levels and is subject to proteasomal degradation

  • Solution: Pre-treat cells with proteasome inhibitors (e.g., MG132, 10 μM for 3-6 hours)

  • Use pervanadate treatment to enhance phosphorylation status

  • Consider alternative lysis buffers: KALB lysis buffer or 1% NP-40 buffer with phosphatase inhibitors

  • Optimize antibody concentration (typically 1:500-1:3000 for Western blotting)

• Multiple bands or unexpected molecular weight:

  • Expected molecular weight for SOCS5 is approximately 61-65 kDa

  • Post-translational modifications may affect migration

  • Degradation products may appear as lower molecular weight bands

  • Solution: Include protease inhibitors in all buffers

  • Validate specificity using SOCS5 knockout or knockdown controls

• Poor immunoprecipitation efficiency:

  • SOCS5 interactions may be transient or weak

  • Solution: Use crosslinking approaches

  • Pre-clear lysates with protein-A-Sepharose for 1.5 hours

  • Optimize antibody amounts for immunoprecipitation (typically 5 μg for endogenous SOCS5)

How should researchers interpret SOCS5 expression data in disease contexts?

When analyzing SOCS5 expression in disease contexts, consider these methodological approaches and interpretative frameworks:

• Viral infections:

  • SOCS5 levels may change differentially in response to different viral strains

  • In influenza infection, reduced SOCS5 levels correlate with increased disease severity

  • Interpret SOCS5 levels in conjunction with viral titers and inflammatory markers

  • Reduced SOCS5 in COPD patients correlates with increased susceptibility to influenza

• Cancer studies:

  • SOCS5 may function as a tumor suppressor in some contexts

  • In T-cell acute lymphoblastic leukemia (T-ALL), SOCS5 negatively regulates cell growth and cell cycle progression

  • Knockdown of SOCS5 in T-ALL cells promotes proliferation and increases cell cycle progression

  • Decreased SOCS5 may correlate with increased JAK-STAT signaling in cancer cells

• Immune cell differentiation:

  • SOCS5 is differentially expressed in Th1 versus Th2 cells

  • Higher SOCS5 in Th1 cells correlates with reduced IL-4 receptor signaling

  • Consider SOCS5:SOCS3 ratios rather than absolute values when assessing T cell polarization

How can researchers validate the specificity of SOCS5 antibodies in their experimental systems?

To ensure the specificity and reliability of SOCS5 antibody results:

• Genetic validation approaches:

  • Use SOCS5 knockout models (e.g., SOCS5-/- mice) as negative controls

  • Employ siRNA or shRNA knockdown of SOCS5 to confirm antibody specificity

  • Overexpress tagged SOCS5 constructs as positive controls

• Biochemical validation:

  • Use peptide competition assays to confirm epitope specificity

  • Compare results with multiple SOCS5 antibodies targeting different epitopes

  • Test cross-reactivity with other SOCS family members (especially SOCS4, which shares structural similarity)

• Functional validation:

  • Correlate SOCS5 antibody detection with expected biological functions

  • In SOCS5-depleted cells, expect enhanced EGFR, JAK, and PI3K signaling

  • In SOCS5-overexpressing cells, expect reduction in these signaling pathways

• Technical controls:

  • Include isotype control antibodies

  • For immunofluorescence studies, include secondary-only controls

  • For immune cell studies, use appropriate lineage markers to contextualize SOCS5 expression

How can SOCS5 antibodies be used to investigate neuroinflammatory responses?

Recent research has identified SOCS5 as an important regulator of neuroinflammation:

• Experimental approaches:

  • Compare wild-type and SOCS5-deficient mice challenged with neurotropic viruses (e.g., Semliki Forest virus)

  • Assess viral replication, inflammatory responses, and immune cell infiltration in the brain

  • Use SOCS5 antibodies to detect protein expression in brain tissues and isolated immune cells

• Key measurements:

  • Brain viral load

  • Inflammatory cytokine and chemokine levels in brain homogenates

  • Immune cell infiltration and phenotyping

  • SOCS5 expression in microglia and infiltrating immune cells

• Expected findings in SOCS5-deficient models:

  • SOCS5-deficient mice show alterations in the pathogenesis and clinical outcome of neurotropic virus infections

  • Elevated levels of pro-inflammatory cytokines (IL-6, RANTES, IFNα, IFNβ)

  • Increased influx of immune cells including CD11b+ cells, neutrophils, inflammatory monocytes, and microglia

  • Higher numbers of antibody-secreting cells, NK1.1+ cells, and CD11c+ cells

What are the latest techniques for studying SOCS5 protein interactions, and how do antibodies facilitate these approaches?

Advanced techniques for studying SOCS5 interactions include:

• Proximity ligation assays:

  • Detect protein-protein interactions in situ

  • Use pairs of antibodies against SOCS5 and potential interacting partners

  • Secondary antibodies conjugated with oligonucleotides enable amplification of signal when proteins are in close proximity

  • Provides spatial information about interactions within cells

• Mass spectrometry-based interaction studies:

  • Immunoprecipitate SOCS5 using specific antibodies

  • Elute with 0.5% sodium dodecyl sulfate (SDS) and 5 mM dithiothreitol (DTT)

  • Perform tryptic digest and analyze by mass spectrometry

  • This approach has identified novel SOCS5 interactions with proteins in the JAK/STAT and EGFR pathways

• SOCS5 ubiquitination studies:

  • Assess SOCS5-mediated ubiquitination of target proteins

  • Use in vitro ubiquitination assays with recombinant components

  • Include E1, E2, Cullin 5, Rbx2, and SOCS5 in complex with Elongin B/C

  • Monitor ubiquitination by immunoblot analysis with target-specific antibodies

How might SOCS5 antibodies contribute to developing therapeutic strategies for viral infections and inflammatory diseases?

SOCS5 antibodies play crucial roles in developing potential therapeutic approaches:

• Diagnostic applications:

  • Monitor SOCS5 levels as biomarkers for susceptibility to viral infections

  • Identify patients with COPD or other inflammatory conditions who might benefit from SOCS5-modulating therapies

  • Assess SOCS5 levels before and after treatment interventions

• Therapeutic target validation:

  • Use antibodies to validate SOCS5 as a therapeutic target

  • In cells from COPD patients, restoration of SOCS5 levels restricts influenza virus infection

  • SOCS5 antibodies can help identify the specific pathways and mechanisms that should be targeted

• Drug development pipelines:

  • Screen compounds that modulate SOCS5 expression or function

  • Use SOCS5 antibodies to monitor changes in protein levels and interactions

  • Assess effects on downstream signaling pathways (JAK/STAT, EGFR, PI3K/AKT)

  • Antibodies enable evaluation of target engagement and mechanism of action